Suppr超能文献

指数生长期、稳定期及同步培养的人结肠癌细胞对亚硝基脲衍生物处理的反应。

Response of exponentially growing, stationary-phase, and synchronized cultured human colon carcinoma cells to treatment with nitrosourea derivatives.

作者信息

Drewinko B, Barlogie B, Freireich E J

出版信息

Cancer Res. 1979 Jul;39(7 Pt 1):2630-6.

PMID:445465
Abstract

The lethal effects of two nitrosourea derivatives, 1,3-bis(2-chloroethyl)-1-nitrosourea and 4-[3-(2-chloroethyl)-3-nitrosoureido]-cis-cyclohexanecarboxylic acid, on a continuous line of human colon carcinoma cells (LoVo cells) were investigated. The survival response of exponentially growing and stationary-phase LoVo cells to both drugs were of the threshold exponential type. Survival was identical whether drugs were dissolved in medium or in Hanks' balanced salt solution. In contrast to previous results obtained for human lymphoma cells, 1,3-bis(2-chloroethyl)-1-nitrosourea exerted a progressively greater killing effect on LoVo cells as the incubation time was prolonged, while 4-[3-(2-chloroethyl)-3-nitrosoureido]-cis-cyclohexane-carboxylic acid, under similar circumstances presented decreased lethality in comparison to both 1,3-bis(2-chloroethyl)-1-nitrosourea and the effect previously observed for the lymphoma cells. Although no recovery from potentially lethal damage was noted for both exponentially growing and stationary-phase cells treated with each agent, in split-dose experiments, LoVo cells were able to recover from sublethal damage. No significant cell cycle stage dependent differences in killing ability were observed for the two agents.

摘要

研究了两种亚硝基脲衍生物,1,3-双(2-氯乙基)-1-亚硝基脲和4-[3-(2-氯乙基)-3-亚硝基脲基]-顺式环己烷羧酸,对人结肠癌细胞连续系(LoVo细胞)的致死作用。指数生长期和静止期LoVo细胞对两种药物的存活反应均为阈值指数型。药物溶解在培养基中还是汉克斯平衡盐溶液中,细胞存活率相同。与先前对人淋巴瘤细胞的研究结果相反,随着孵育时间延长,1,3-双(2-氯乙基)-1-亚硝基脲对LoVo细胞的杀伤作用逐渐增强,而在类似情况下,4-[3-(2-氯乙基)-3-亚硝基脲基]-顺式环己烷羧酸与1,3-双(2-氯乙基)-1-亚硝基脲相比致死率降低,且与先前观察到的对淋巴瘤细胞的作用相比也降低。虽然用每种药物处理的指数生长期和静止期细胞均未观察到从潜在致死损伤中恢复,但在分次给药实验中,LoVo细胞能够从亚致死损伤中恢复。两种药物在杀伤能力上未观察到明显的细胞周期阶段依赖性差异。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验